Immunogen Inc. (IMGN) PT Lowered to $4 at Guggenheim

March 1, 2019 2:49 PM EST Send to a Friend
Guggenheim analyst Michael Schmidt lowered the price target on Immunogen Inc. (NASDAQ: IMGN) to $4.00 (from $16.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login